212 related articles for article (PubMed ID: 36140775)
41. Cerebral protein synthesis in a knockin mouse model of the fragile X premutation.
Qin M; Huang T; Liu Z; Kader M; Burlin T; Xia Z; Zeidler Z; Hukema RK; Smith CB
ASN Neuro; 2014; 6(5):. PubMed ID: 25290064
[TBL] [Abstract][Full Text] [Related]
42. Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array.
Schenkel LC; Schwartz C; Skinner C; Rodenhiser DI; Ainsworth PJ; Pare G; Sadikovic B
J Mol Diagn; 2016 Nov; 18(6):834-841. PubMed ID: 27585064
[TBL] [Abstract][Full Text] [Related]
43. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
[TBL] [Abstract][Full Text] [Related]
44. Mosaicism in a fragile X male including a de novo deletion in the FMR1 gene.
Petek E; Kroisel PM; Schuster M; Zierler H; Wagner K
Am J Med Genet; 1999 May; 84(3):229-32. PubMed ID: 10331598
[TBL] [Abstract][Full Text] [Related]
45. Identification of a novel epigenetic marker for typical and mosaic presentations of Fragile X syndrome.
da Silva CP; Camuzi D; Reis AHO; Gonçalves AP; Dos Santos JM; Machado FB; Medina-Acosta E; Soares-Lima SC; Santos-Rebouças CB
Expert Rev Mol Diagn; 2023; 23(12):1273-1281. PubMed ID: 37970883
[TBL] [Abstract][Full Text] [Related]
46. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients.
Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z
Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181
[TBL] [Abstract][Full Text] [Related]
47. Methylated premutation of the FMR1 gene in three sisters: correlating CGG expansion and epigenetic inactivation.
Tabolacci E; Pomponi MG; Remondini L; Pietrobono R; Nobile V; Pennacchio G; Gurrieri F; Neri G; Genuardi M; Chiurazzi P
Eur J Hum Genet; 2020 May; 28(5):567-575. PubMed ID: 31804632
[TBL] [Abstract][Full Text] [Related]
48. Establishment of FXS-A9 panel with a single human X chromosome from fragile X syndrome-associated individual.
Nakayama Y; Adachi K; Shioda N; Maeta S; Nanba E; Kugoh H
Exp Cell Res; 2021 Jan; 398(2):112419. PubMed ID: 33296661
[TBL] [Abstract][Full Text] [Related]
49. Significantly Elevated
Field M; Dudding-Byth T; Arpone M; Baker EK; Aliaga SM; Rogers C; Hickerton C; Francis D; Phelan DG; Palmer EE; Amor DJ; Slater H; Bretherton L; Ling L; Godler DE
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405222
[TBL] [Abstract][Full Text] [Related]
50. Fragile X syndrome full mutation in cognitively normal male identified as part of an Australian reproductive carrier screening program.
Jarmolowicz AI; Baker EK; Bartlett E; Francis D; Ling L; Gamage D; Delatycki MB; Godler DE
Am J Med Genet A; 2021 May; 185(5):1498-1503. PubMed ID: 33544979
[TBL] [Abstract][Full Text] [Related]
51. CGG repeat in the FMR1 gene: size matters.
Willemsen R; Levenga J; Oostra BA
Clin Genet; 2011 Sep; 80(3):214-25. PubMed ID: 21651511
[TBL] [Abstract][Full Text] [Related]
52. A sensitive and reproducible qRT-PCR assay detects physiological relevant trace levels of FMR1 mRNA in individuals with Fragile X syndrome.
Straub D; Schmitt LM; Boggs AE; Horn PS; Dominick KC; Gross C; Erickson CA
Sci Rep; 2023 Mar; 13(1):3808. PubMed ID: 36882476
[TBL] [Abstract][Full Text] [Related]
53. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
[TBL] [Abstract][Full Text] [Related]
54. DNA Methylation, Mechanisms of
Nobile V; Pucci C; Chiurazzi P; Neri G; Tabolacci E
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669384
[TBL] [Abstract][Full Text] [Related]
55. High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome.
Basuta K; Schneider A; Gane L; Polussa J; Woodruff B; Pretto D; Hagerman R; Tassone F
Am J Med Genet A; 2015 Sep; 167A(9):2154-61. PubMed ID: 25920745
[TBL] [Abstract][Full Text] [Related]
56. Altered neural activity of magnitude estimation processing in adults with the fragile X premutation.
Kim SY; Hashimoto R; Tassone F; Simon TJ; Rivera SM
J Psychiatr Res; 2013 Dec; 47(12):1909-16. PubMed ID: 24045061
[TBL] [Abstract][Full Text] [Related]
57. Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons.
Graef JD; Wu H; Ng C; Sun C; Villegas V; Qadir D; Jesseman K; Warren ST; Jaenisch R; Cacace A; Wallace O
Eur J Neurosci; 2020 May; 51(10):2143-2157. PubMed ID: 31880363
[TBL] [Abstract][Full Text] [Related]
58. Altered neural activity in the 'when' pathway during temporal processing in fragile X premutation carriers.
Kim SY; Tassone F; Simon TJ; Rivera SM
Behav Brain Res; 2014 Mar; 261():240-8. PubMed ID: 24398265
[TBL] [Abstract][Full Text] [Related]
59. Transcription of the FMR1 gene in individuals with fragile X syndrome.
Tassone F; Hagerman RJ; Chamberlain WD; Hagerman PJ
Am J Med Genet; 2000; 97(3):195-203. PubMed ID: 11449488
[TBL] [Abstract][Full Text] [Related]
60. Mosaicism for the full mutation and a microdeletion involving the CGG repeat and flanking sequences in the FMR1 gene in eight fragile X patients.
Grasso M; Faravelli F; Lo Nigro C; Chiurazzi P; Sperandeo MP; Argusti A; Pomponi MG; Lecora M; Sebastio GF; Perroni L; Andria G; Neri G; Bricarelli FD
Am J Med Genet; 1999 Jul; 85(3):311-6. PubMed ID: 10398249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
